(RYN) Rayonier - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7549071030
Timber, Land, Real Estate, REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.45% |
| Yield on Cost 5y | 10.83% |
| Yield CAGR 5y | 23.25% |
| Payout Consistency | 93.3% |
| Payout Ratio | 69.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.2% |
| Value at Risk 5%th | 36.0% |
| Relative Tail Risk | -9.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -9.91 |
| CAGR/Max DD | -0.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.396 |
| Beta | 0.493 |
| Beta Downside | 0.676 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.63% |
| Mean DD | 16.37% |
| Median DD | 16.08% |
Description: RYN Rayonier January 12, 2026
Rayonier Inc. (NYSE:RYN) is a timberland REIT that, as of June 30 2025, owned or held long-term leases on roughly 2.0 million acres of productive softwood timberlands-about 1.74 million acres in the U.S. South and 307,000 acres in the Pacific Northwest.
Key recent metrics: FY 2024 saw adjusted EBITDA of $1.1 billion, supporting a dividend yield near 6.5%; the company’s timber price index rose ~4 % year-over-year, driven by strong housing starts and lumber demand. A primary sector driver is the long-term upward trend in construction activity, while climate-risk exposure (wildfire and disease) remains a material uncertainty that management mitigates through diversified geography and active forest management.
For a deeper dive into Rayonier’s valuation nuances and how they compare to peers, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (775.6m TTM) > 0 and > 6% of Revenue (6% = 65.6m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 63.15% (prev 15.71%; Δ 47.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 292.7m <= Net Income 775.6m (YES >=105%, WARN >=100%) |
| Net Debt (141.1m) to EBITDA (504.6m) ratio: 0.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (156.4m) change vs 12m ago 3.35% (target <= -2.0% for YES) |
| Gross Margin 42.85% (prev 29.55%; Δ 13.30pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 31.37% (prev 25.17%; Δ 6.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 15.09 (EBITDA TTM 504.6m / Interest Expense TTM 27.1m) >= 6 (WARN >= 3) |
Altman Z'' 4.62
| (A) 0.20 = (Total Current Assets 972.9m - Total Current Liabilities 282.6m) / Total Assets 3.49b |
| (B) 0.15 = Retained Earnings (Balance) 514.2m / Total Assets 3.49b |
| (C) 0.12 = EBIT TTM 409.0m / Avg Total Assets 3.49b |
| (D) 1.95 = Book Value of Equity 2.28b / Total Liabilities 1.17b |
| Total Rating: 4.62 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.97
| 1. Piotroski 5.0pt |
| 2. FCF Yield 5.35% |
| 3. FCF Margin 19.39% |
| 4. Debt/Equity 0.47 |
| 5. Debt/Ebitda 0.28 |
| 6. ROIC - WACC (= 6.74)% |
| 7. RoE 37.54% |
| 8. Rev. Trend -30.90% |
| 9. EPS Trend 40.13% |
What is the price of RYN shares?
As of January 14, 2026, the stock is trading at USD 23.06 with a total of 1,205,366 shares traded.
Over the past week, the price has changed by +5.68%, over one month by +4.68%, over three months by -4.40% and over the past year by +0.66%.
Over the past week, the price has changed by +5.68%, over one month by +4.68%, over three months by -4.40% and over the past year by +0.66%.
Is RYN a buy, sell or hold?
Rayonier has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold RYN.
- Strong Buy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RYN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.7 | 15.7% |
| Analysts Target Price | 26.7 | 15.7% |
| ValueRay Target Price | 25.6 | 10.8% |
RYN Fundamental Data Overview January 11, 2026
P/E Trailing = 9.0192
P/E Forward = 40.0
P/S = 2.9559
P/B = 1.5897
P/EG = 23.2357
Beta = 0.987
Revenue TTM = 1.09b USD
EBIT TTM = 409.0m USD
EBITDA TTM = 504.6m USD
Long Term Debt = 845.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 141.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.96b USD (3.82b + Debt 1.06b - CCE 919.6m)
Interest Coverage Ratio = 15.09 (Ebit TTM 409.0m / Interest Expense TTM 27.1m)
EV/FCF = 18.70x (Enterprise Value 3.96b / FCF TTM 211.9m)
FCF Yield = 5.35% (FCF TTM 211.9m / Enterprise Value 3.96b)
FCF Margin = 19.39% (FCF TTM 211.9m / Revenue TTM 1.09b)
Net Margin = 70.95% (Net Income TTM 775.6m / Revenue TTM 1.09b)
Gross Margin = 42.85% ((Revenue TTM 1.09b - Cost of Revenue TTM 624.8m) / Revenue TTM)
Gross Margin QoQ = 32.90% (prev 29.69%)
Tobins Q-Ratio = 1.14 (Enterprise Value 3.96b / Total Assets 3.49b)
Interest Expense / Debt = 0.64% (Interest Expense 6.80m / Debt 1.06b)
Taxrate = 1.14% (500.0k / 43.7m)
NOPAT = 404.3m (EBIT 409.0m * (1 - 1.14%))
Current Ratio = 3.44 (Total Current Assets 972.9m / Total Current Liabilities 282.6m)
Debt / Equity = 0.47 (Debt 1.06b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 0.28 (Net Debt 141.1m / EBITDA 504.6m)
Debt / FCF = 0.67 (Net Debt 141.1m / FCF TTM 211.9m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.25% (Net Income 775.6m / Total Assets 3.49b)
RoE = 37.54% (Net Income TTM 775.6m / Total Stockholder Equity 2.07b)
RoCE = 14.05% (EBIT 409.0m / Capital Employed (Equity 2.07b + L.T.Debt 845.1m))
RoIC = 12.93% (NOPAT 404.3m / Invested Capital 3.13b)
WACC = 6.19% (E(3.82b)/V(4.88b) * Re(7.73%) + D(1.06b)/V(4.88b) * Rd(0.64%) * (1-Tc(0.01)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.70%
[DCF Debug] Terminal Value 79.24% ; FCFF base≈200.3m ; Y1≈131.5m ; Y5≈60.0m
Fair Price DCF = 9.99 (EV 1.75b - Net Debt 141.1m = Equity 1.61b / Shares 161.4m; r=6.19% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.13 | EPS CAGR: 152.0% | SUE: 0.11 | # QB: 0
Revenue Correlation: -30.90 | Revenue CAGR: -9.86% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.035 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.47 | Chg30d=-0.008 | Revisions Net=-3 | Growth EPS=-2.9% | Growth Revenue=-0.9%
P/E Forward = 40.0
P/S = 2.9559
P/B = 1.5897
P/EG = 23.2357
Beta = 0.987
Revenue TTM = 1.09b USD
EBIT TTM = 409.0m USD
EBITDA TTM = 504.6m USD
Long Term Debt = 845.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 141.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.96b USD (3.82b + Debt 1.06b - CCE 919.6m)
Interest Coverage Ratio = 15.09 (Ebit TTM 409.0m / Interest Expense TTM 27.1m)
EV/FCF = 18.70x (Enterprise Value 3.96b / FCF TTM 211.9m)
FCF Yield = 5.35% (FCF TTM 211.9m / Enterprise Value 3.96b)
FCF Margin = 19.39% (FCF TTM 211.9m / Revenue TTM 1.09b)
Net Margin = 70.95% (Net Income TTM 775.6m / Revenue TTM 1.09b)
Gross Margin = 42.85% ((Revenue TTM 1.09b - Cost of Revenue TTM 624.8m) / Revenue TTM)
Gross Margin QoQ = 32.90% (prev 29.69%)
Tobins Q-Ratio = 1.14 (Enterprise Value 3.96b / Total Assets 3.49b)
Interest Expense / Debt = 0.64% (Interest Expense 6.80m / Debt 1.06b)
Taxrate = 1.14% (500.0k / 43.7m)
NOPAT = 404.3m (EBIT 409.0m * (1 - 1.14%))
Current Ratio = 3.44 (Total Current Assets 972.9m / Total Current Liabilities 282.6m)
Debt / Equity = 0.47 (Debt 1.06b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 0.28 (Net Debt 141.1m / EBITDA 504.6m)
Debt / FCF = 0.67 (Net Debt 141.1m / FCF TTM 211.9m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.25% (Net Income 775.6m / Total Assets 3.49b)
RoE = 37.54% (Net Income TTM 775.6m / Total Stockholder Equity 2.07b)
RoCE = 14.05% (EBIT 409.0m / Capital Employed (Equity 2.07b + L.T.Debt 845.1m))
RoIC = 12.93% (NOPAT 404.3m / Invested Capital 3.13b)
WACC = 6.19% (E(3.82b)/V(4.88b) * Re(7.73%) + D(1.06b)/V(4.88b) * Rd(0.64%) * (1-Tc(0.01)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.70%
[DCF Debug] Terminal Value 79.24% ; FCFF base≈200.3m ; Y1≈131.5m ; Y5≈60.0m
Fair Price DCF = 9.99 (EV 1.75b - Net Debt 141.1m = Equity 1.61b / Shares 161.4m; r=6.19% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.13 | EPS CAGR: 152.0% | SUE: 0.11 | # QB: 0
Revenue Correlation: -30.90 | Revenue CAGR: -9.86% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.035 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.47 | Chg30d=-0.008 | Revisions Net=-3 | Growth EPS=-2.9% | Growth Revenue=-0.9%
Additional Sources for RYN Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle